Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
K. A. Malle Pharmaceuticals is an Indian manufacturer of active pharmaceutical ingredients, drug intermediates, specialty chemicals, and hydrogenation-based contract manufacturing services. The company markets itself as a leading producer of mebendazole and albendazole, and it also lists sodium carboxy methyl cellulose and chemical intermediates such as meta bromo anisole and meta phenoxy benzyl alcohol among its products. Its business appears to be primarily B2B manufacturing rather than novel drug discovery, with commercial production, export supply, and custom process chemistry capabilities. The company states that it operates an in-house R&D center, serves multinational chemical and pharmaceutical customers, and exports to numerous countries. Its headquarters are in Mumbai, with a manufacturing plant in Ankleshwar, Gujarat.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on K.A. Malle Pharmaceuticals.